GLP-1 receptor agonist initiation was also linked to reduced risks for SUD-related adverse events for people with preexisting SUD. HealthDay News — The use of glucagon-like peptide-1 (GLP-1) receptor ...

Discover the truth about using vanilla extract in recipes! In this video, we explain how real and imitation vanilla affect flavor, the best ways to use it in baking and cooking, and tips to enhance ...

In chemistry, some problems are so persistent that they are nicknamed “forever.” Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are notorious environmental villains. These compounds linger in ...

About The Study: Among metabolic and bariatric surgery (MBS)-eligible patients in a national sample, semaglutide and tirzepatide prescriptions increased dramatically between 2018 and 2025, whereas MBS ...

The risk for nonscarring hair loss (NSHL) is increased in association with glucagon-like peptide-1 receptor agonist (GLP-1 RA) use, according to a study published online Feb. 9 in the Journal of the ...

Krista McCay is a writer specializing in video game guides and walkthroughs. She first entered the industry in 2022 while studying English at UC Santa Barbara and working part-time as an editor. It ...

As shown in the screenshot, you only need to describe your needs in everyday language, and the AI will directly control PyMOL to complete complex molecular visualization tasks.

The only GLP-1 RA agent to show significant benefit for colorectal cancer incidence risk was semaglutide. HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a ...

GLP-1 receptor agonist (RA) prescribing increased from 0.2 to 6.4 per 1000 deliveries predelivery and from 0.3 to 14.6 per 1000 deliveries postdelivery between 2019 and 2024. Among recipients in 2024, ...

Intra-arterial gemcitabine versus intravenous gemcitabine: Pharmacokinetic and pharmacodynamic sub-study of the TIGeR-PaC phase 3 clinical trial. This is an ASCO Meeting Abstract from the 2026 ASCO ...